EC Number | Application | Comment | Organism |
---|---|---|---|
3.5.4.4 | medicine | therapy for adenosine-deficient patients with combined immunodeficiency | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.5.4.4 | aza adenosine analogues | - |
Homo sapiens | |
3.5.4.4 | deaza adenosine analogues | - |
Homo sapiens | |
3.5.4.4 | Deoxycoformycin | - |
Homo sapiens | |
3.5.4.4 | erythro-9-(2-hydroxy-3-nonyl)adenine | - |
Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.5.4.4 | 0.033 | - |
adenosine | - |
Homo sapiens | |
3.5.4.4 | 0.052 | - |
2'-deoxyadenosine | - |
Homo sapiens | |
3.5.4.4 | 0.081 | - |
6-methoxypurinriboside | - |
Homo sapiens | |
3.5.4.4 | 0.277 | - |
6-chloropurinriboside | - |
Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.4.4 | Homo sapiens | - |
normal B-cells and T-cell lines MOLT-4 | - |
3.5.4.4 | Homo sapiens | - |
RPMI-8402 | - |
3.5.4.4 | Homo sapiens | - |
CCRF-CEM | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.5.4.4 | placenta | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.4.4 | 2'-deoxyadenosine + H2O | - |
Homo sapiens | 2'-deoxyinosine + NH3 | - |
? | |
3.5.4.4 | 6-chloropurine riboside + H2O | - |
Homo sapiens | inosine + Cl- | - |
? | |
3.5.4.4 | 6-chloropurinriboside + H2O | - |
Homo sapiens | inosine + Cl- | - |
? | |
3.5.4.4 | 6-methoxypurinriboside | - |
Homo sapiens | ? | - |
? | |
3.5.4.4 | adenosine + H2O | - |
Homo sapiens | inosine + NH3 | - |
? |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.5.4.4 | 7 | - |
- |
Homo sapiens |